迈得医疗：预计2025年盈利6652.13万元 同比扭亏

Core Viewpoint - The company Maide Medical (688310) expects a significant turnaround in its financial performance for the year 2025, projecting a net profit of 66.52 million yuan compared to a loss of 19.98 million yuan in the previous year [4]. Financial Performance - The projected net profit for 2025 is 66.52 million yuan, while the expected non-recurring net profit is 54.64 million yuan, showing substantial improvement from losses of 19.98 million yuan and 26.28 million yuan, respectively, in the previous year [4]. - The company's price-to-earnings (P/E) ratio is approximately 40.63 times, the price-to-book (P/B) ratio is about 3.35 times, and the price-to-sales (P/S) ratio is around 9.66 times based on the closing price on January 26 [4]. Revenue Growth - The company anticipates significant revenue growth in 2025, driven by effective production planning and a focus on technological innovation and process iteration, which enhance product competitiveness and market influence [13]. - The blood purification and drug-device combination intelligent equipment business segments are performing well, particularly due to strong demand growth in the terminal market for medical consumables [13]. Historical Financial Trends - Historical data indicates a trend of increasing net profit and non-recurring net profit, with the company projecting a recovery in profitability for 2025 after previous losses [14]. - The year-on-year growth rates for net profit and non-recurring net profit are expected to show significant improvement, reflecting the company's recovery trajectory [14].